FENCF

 
Ordinary Shares SEC Reporting - Current
OTCQB
Verified Company Profile 9/27/2016
Contact Info
  • 68 T W Alexander Drive
  • PO Box 13628
  • Research Triangle Pa, NC 27709

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001211583
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 1996
Employees 3 a/o Mar 31, 2015
Company Officers/Contacts
Rostislav Raykov CEO
Robert Andrade CFO
Mark Gowland Controller
Company Directors
Khalid Islam Chairman
Marco Brughera
Adrian Haigh
Chris A. Rallis
Rostislav Raykov
Company Notes
  • Formerly=Adherex Technologies Inc. until 9-2014
  • Note=9-30-04 company is in the development stage
Service Providers
Accounting/Auditing Firm
Deloitte & Touche LLP
225 W. Santa Clara St.
San Jose, CA, 95113
United States

Legal Counsel
LeBarge Weinstein
515 Legget Drive
Suite 800
Ottawa, ONT, K2K 3G4
Canada

Investor Relations Firm
Not Available
FENCF Security Details
Share Structure
Market Value1 $25,409,281 a/o Dec 01, 2016
Authorized Shares Unlimited a/o Mar 31, 2015
Outstanding Shares 13,642,567 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders
Shareholders of Record 51 a/o Mar 28, 2016
Non US Stock Exchange Listing
FRX - Toronto Stock Exchange - Qualified
Short Selling Data
Short Interest 1,955 (569.52%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security